Vision and emotions in Parkinson's disease
Part of Brain & nervous system clinical trials.
This study explores how Parkinson's disease affects visual and emotional abilities. It aims to understand these challenges better to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are right-handed
- You have been diagnosed with Parkinson's disease
- Your Parkinson's is in an early stage (Hoehn and Yahr less than 2.5)
- Your Parkinson's medications have been stable for at least 6 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Parkinson disease affects the connection between vision and movement. You will be asked to view a computer screen and perform simple tasks to help researchers understand these changes.
This study tests digital devices that may help track Parkinson's symptoms using eye movements and balance. It is designed for people with Parkinson's or related conditions who have trouble with walking (freezing) and can walk for at least 5 minutes.
This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.
This study uses a simple eye-tracking test to see if eye movement patterns can help tell the difference between Parkinson's disease and similar conditions like PSP or MSA. It aims to find a faster, easier way to diagnose these disorders.
This study uses a simple eye movement test to see if it can help tell the difference between Parkinson's disease, Essential tremor, and healthy people. The goal is to find a better way to diagnose and track these conditions.
This study uses artificial intelligence to analyze videos of standard motor tests (MDS-UPDRS Part III) for people with Parkinson's disease. It aims to see if AI can reliably assess your symptoms, which could lead to easier, more accessible monitoring in the future.
Hear when a new Alexithymia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.